We performed triple immunostaining for α‐SMA, CD34, and IL32 on tumor sections to quantify the percentage of pericyte‐IL32 positive blood vessels in each patient, indicating that IL32 was expressed in PCs (Figures 1K,L). The gene discussed is IL32; the disease is neoplasm.